Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
5.50
-0.49 (-8.18%)
Aug 18, 2026, 4:00 PM EST
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $848.95 million as of August 19, 2026. Its market cap has increased by 227.68% in one year.
Market Cap
848.95M
Enterprise Value
777.01M
Revenue
615.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
$5.50
ChartMarket Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has increased from 538.37M to 848.95M, an increase of 57.69%. That is a compound annual growth rate of 7.96%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 18, 2026 | 848.95M | 195.61% |
| Dec 31, 2025 | 287.18M | -11.59% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Sep 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Northwest Biotherapeutics | 324.11M |
| CytoDyn | 260.45M |
| Glorywin Entertainment Group | 182.41M |
| Vaxart | 131.98M |
| HST Global | 91.93M |
| NDT Pharmaceuticals | 88.99M |
| Sangamo Therapeutics | 72.50M |
| Arch Biopartners | 56.03M |